As demonstrated in this study, EZH2, which acts as a potential oncogene in various malignancies, plays an active role in the upregulation of MMP activity and promote ECM degradation and subsequent invasion of prostate cancer cells, providing a novel insight into the role of EZH2 in prostate cancer metastasis. Here, EZH2 is linked to Familial prostate cancer.